As previously reported, BNP Paribas Exane downgraded Constellation Brands (STZ) to Underperform from Neutral with a price target of $123, down from $181, following the company’s FY26 guidance cut. The firm’s “increasingly bearish thesis” is based on persisting, structurally skewed demand issues, notes the analyst, who sees long-term beer operating margins as the “next shoe to drop” as volume pressures continue. The firm adds that its FY27 and FY28 EPS estimates are 16% and 23% below consensus, respectively.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STZ:
- Constellation Brands downgraded to Underperform from Neutral at BNP Paribas Exane
- Constellation Brands Faces Downgrade Amid Declining Beer Sales and Operating Income Challenges
- “…Dampened Consumer Demand”: Constellation Brands Stock (NYSE:STZ) Plunges After Outlook Cut
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
- Constellation Brands price target lowered to $196 from $225 at Goldman Sachs